|
| 2012~2014年某院新农合心脏外科按病种付费费用分析 |
| Cost analysis of drug related groups payment by new rural cooperative medical care in cardiac surgery department of a hospital from 2012 to 2014 |
| 投稿时间：2015-06-02 修订日期：2015-08-05 |
| DOI：10.3969/j.issn.1000-0399.2015.12.033 |
| 中文关键词: 新型农村合作医疗 按病种付费 心脏外科 三级医院 |
| 英文关键词: New rural cooperative medical care Drug related groups payment Cardiac surgery Tertiary hospital |
| 基金项目:安徽省科技厅软科学研究计划资助(项目编号:1502052067) |
|
| 摘要点击次数: 1888 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的 分析心脏外科重大疾病按病种付费的总费用及结构,了解费用控制效果.方法 通过医院信息系统回顾性收集2012~2014年的心脏外科重大疾病按病种付费的统计信息,并进行统计描述.结果 4种心脏外科重大疾病按病种付费的病例数由161例增加到242例,4种疾病的人均费用呈上升趋势,超标费用标准差较大,超标比例最高达100%,绝大多数药品费用比例在30%以下.结论 心脏外科按病种付费的限额标准仍是关键性问题,不同病种费用控制效果存在差异,药品费用控制效果较好. |
| 英文摘要: |
| Objective To analyze the total cost and cost structure, and understand the effect of cost control for serious disease of cardiac surgery after conducting drug related groups payment (DRGs) by new rural cooperative medical care. Methods Information about DRGs of serious diseases in cardiac surgery department through the hospital information system was retrospectively collected from 2012 to 2014 and were analyzed by statistic description method. Results The cases increased from 161 in 2012 to 242 in 2014 of DRGs for four major diseases of cardiac surgery department. The hospital cost per capita was on the rise. The standard of the excessive fee was larger. The highest percentage of excessive fee was 100%. The vast majority of drug cost ratio was below 30%. Conclusion Hospital cost limits are still the key issues for serious diseases of cardiac surgery department. Cost control effect for different diseases are different. Drug cost control effect is better. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
